Detalhe da pesquisa
1.
Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.
Int J Clin Oncol
; 28(8): 1054-1062, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261583
2.
[Association of D-dimer Levels with Complications after Subcutaneous Implantable Central Venous Port Placement in Combination Chemotherapy with Bevacizumab for Colorectal Cancer].
Gan To Kagaku Ryoho
; 50(6): 713-717, 2023 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-37317606
3.
[Exploratory Study of the Risk Factors for Acute Kidney Injury in the Cisplatin Combination Chemotherapy for Solid Cancer].
Gan To Kagaku Ryoho
; 47(12): 1697-1702, 2020 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-33342986
4.
[Risk Factors of Thromboembolism in Colorectal Cancer Patients Receiving Combination Chemotherapy with Bevacizumab].
Gan To Kagaku Ryoho
; 46(10): 1531-1535, 2019 Oct.
Artigo
em Japonês
| MEDLINE | ID: mdl-31631134
5.
[Survey of Cholinergic Symptoms in Patients with Colorectal Cancer Who Were Receiving Irinotecan Hydrochloride Combination Chemotherapy].
Gan To Kagaku Ryoho
; 45(11): 1619-1623, 2018 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-30449850
6.
Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan.
J Oncol Pharm Pract
; 26(6): 1553-1554, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469683
7.
[Associations between Clinical Factors and Acute Renal Failure Due to Cisplatin Combination Chemotherapy for Lung Cancer].
Gan To Kagaku Ryoho
; 42(11): 1379-83, 2015 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-26602395
8.
[Risk factors for cardiotoxicity during fluorouracil and cisplatin combination chemotherapy].
Gan To Kagaku Ryoho
; 41(5): 601-4, 2014 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-24917005
9.
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).
Drug Saf
; 46(6): 545-552, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106270
10.
Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
J Clin Pharmacol
; 63(4): 473-479, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453166
11.
Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database.
Int J Clin Pharm
; 44(1): 260-263, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482500
12.
Identification of inhibitory component in cinnamon--O-methoxycinnamaldehyde inhibits CYP1A2 and CYP2E1-.
Drug Metab Pharmacokinet
; 17(3): 229-36, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-15618674